Retinoic Acid Receptors in Metastatic Prostate Cancer
Abstract
This project is a study of the potential role of retinoic acid receptor in the metastasis of prostate cancer. Initial studies identified the RXR-alpha expression to be highly correlated with retinoid sensitivity. In addition, clinical samples showed a trend towards a decreased expression in metastatic cells compared to the primary tumor cells. To determine the function of the retinoid receptor RXR-alpha, an adenovirus transducing RXR-alpha was created and tested in two ways. Prostate cancer cell lines were created to over express the gene. These RXR-alpha transduced cells were showed no change in the sensitivity to retinoids and the metastatic ability when used in a nude mouse model of experimental metastasis, a technique that was also newly developed in this study.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 1999
- Accession Number
- ADA388557
Entities
People
- Kenichi Takeshita
Organizations
- NYU Langone Health